FPRX

Five Prime Therapeutics, Inc.

FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

103 hedge funds and large institutions have $105M invested in Five Prime Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 24 closing their positions.

2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

103

Holders Change

-11

Holders Change %

-9.65%

% of All Funds

2.26%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

$500K

Net Calls

-$500K

Net Calls Change

-$258K

Top Buyers

1	BI 1 BVF Inc San Francisco, California	$14.6M
2	RSCM 2 Rock Springs Capital Management Baltimore, Maryland	$3M
3	3 Renaissance Technologies New York	$5.17M
4	4 Man Group London, United Kingdom	$5.18M
5	5 Squarepoint New York	$805K

Top Sellers

1	1 Fidelity Investments Boston, Massachusetts	$1.17M
2	GPP 2 Great Point Partners Greenwich, Connecticut	$0
3	3 Wellington Management Group Boston, Massachusetts	$9.38M
4	4 Axa Paris, France	$1.23M
5	5 Goldman Sachs New York	$333K

#	Name	Holding	Trade Value	Shares Change	Shares Change %
26	26 Squarepoint New York	$805K	+$672K	+173,581	+507%
27	27 Two Sigma Advisers New York	$777K	+$55.4K	+14,300	+8%
28	28 D.E. Shaw & Co New York	$747K	+$411K	+106,048	+122%
29	PIM 29 Platinum Investment Management Sydney Australia 2000, Australia	$741K	–	–	–
30	30 Two Sigma Investments New York	$695K	-$239K	-61,677	-26%
31	31 Morgan Stanley New York	$624K	-$376K	-97,137	-38%
32	32 Bank of New York Mellon New York	$612K	-$9.49K	-2,450	-2%
33	33 Acadian Asset Management Boston, Massachusetts	$606K	+$49.3K	+12,713	+9%
34	WCM 34 Weld Capital Management New York	$598K	+$152K	+39,345	+34%
35	ARTA 35 A.R.T. Advisors New York	$533K	+$128K	+33,000	+32%
36	36 AQR Capital Management Greenwich, Connecticut	$533K	+$533K	+137,571	New
37	37 Jacobs Levy Equity Management Florham Park, New Jersey	$470K	+$322K	+82,983	+217%
38	38 UBS Group Zurich, Switzerland	$462K	+$454K	+117,135	+5,637%
39	39 Macquarie Group Sydney, NSW 2000, Australia	$388K	–	–	–
40	40 Tudor Investment Corp Stamford, Connecticut	$355K	+$6.97K	+1,800	+2%
41	AGA 41 Altrinsic Global Advisors Stamford, Connecticut	$349K	–	–	–
42	PP 42 PDT Partners New York	$342K	+$342K	+88,300	New
43	43 Goldman Sachs New York	$333K	-$639K	-165,075	-66%
44	44 Wells Fargo San Francisco, California	$278K	-$28.9K	-7,453	-9%
45	45 Susquehanna International Group Bala Cynwyd, Pennsylvania	$260K	-$29.6K	-7,635	-10%
46	AG 46 Algert Global San Francisco, California	$248K	+$64.4K	+16,640	+35%
47	47 AllianceBernstein Nashville, Tennessee	$234K	–	–	–
48	48 RhumbLine Advisers Boston, Massachusetts	$222K	+$18.1K	+4,657	+9%
49	49 Swiss National Bank Zurich, Switzerland	$218K	–	–	–
50	PPA 50 Parametric Portfolio Associates Seattle, Washington	$218K	+$44.4K	+11,459	+26%

Five Prime Therapeutics, Inc. FPRX

Top Buyers

Top Sellers

Five Prime Therapeutics, Inc.

FPRX